| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/07/2011 | CN102271530A 用于治疗和预防伴侣动物的与体重相关疾病的组合物和方法 Compositions and methods of treating and preventing companion animal for weight-related disorders |
| 12/07/2011 | CN102271529A 包含硫辛酸的陪伴动物组合物及其使用方法 Companion animal compositions comprising lipoic acid and methods of use |
| 12/07/2011 | CN102268338A Myotonin wine and kiln pool mud for wine |
| 12/07/2011 | CN102267993A 一种多羟基去甲基托品烷类化合物及其制备方法与应用 A base plate to a polyhydroxy alkyl compounds product and its preparation method and application |
| 12/07/2011 | CN102267977A 一种3-取代苯并[c]呋喃酮的硫代、硒代同系物、其制备方法及医药用途 One 3-substituted benzo [c] furan ketone thio, seleno homologues, their preparation and pharmaceutical use |
| 12/07/2011 | CN102267959A 一种瑞格列奈晶体、其制备方法及含有该晶体的固体口服制剂 One kind of repaglinide crystal, its preparation method and containing a solid oral formulations of the crystal |
| 12/07/2011 | CN102266559A 包含替米沙坦盐和钙离子拮抗剂的药物组合物 Containing salts and calcium antagonist telmisartan pharmaceutical composition |
| 12/07/2011 | CN102266525A 治疗糖尿病的药物 Diabetes drug |
| 12/07/2011 | CN102266520A 一种治疗糖尿病的中药组合物 Chinese medicine for treating diabetes composition |
| 12/07/2011 | CN102266487A 治疗高脂血症的含葛根组合物及制备方法和应用 Treatment of hyperlipidemia containing Pueraria composition and preparation method and application |
| 12/07/2011 | CN102266472A 预防和/或治疗糖尿病肾病的中药组合物及其制备方法 Prevention and / or treatment of diabetic nephropathy in Chinese medicine composition and its preparation method |
| 12/07/2011 | CN102266468A 一种降血压血糖的保健酒 A Reduced blood pressure and blood sugar health wine |
| 12/07/2011 | CN102266429A 一种沙棘籽提取物与山茶油的混合物及其制备方法 One kind of sea buckthorn seed extract and camellia oil mixture and its preparation method |
| 12/07/2011 | CN102266414A 一种具有减肥降脂功能的外用中草药 Topical herbal kind of lipid-lowering diet function |
| 12/07/2011 | CN102266394A 治疗心肺疾病、糖尿病、脉管炎的外用药及其应用 Treatment of heart and lung disease, diabetes, vasculitis external use and its application |
| 12/07/2011 | CN102266391A 可同时调节餐后和空腹血糖的药食同源植物提取的组合物 Simultaneously regulate postprandial and fasting glucose Medicinal and Edible Plants extract composition |
| 12/07/2011 | CN102266388A 一种用于2型糖尿病及并发症预防和治疗的药物组合物 A pharmaceutical composition for the prevention of type 2 diabetes and complications and treatment |
| 12/07/2011 | CN102266368A 一种具有调节血脂、延缓衰老的中药组合物及制造方法 Chinese medicinal composition and manufacturing methods regulate blood lipids, anti-aging has |
| 12/07/2011 | CN102266360A 一种从西青果中提取α-葡萄糖苷酶抑制剂的方法 A method of extracting fruit from the west in α- glucosidase inhibitors |
| 12/07/2011 | CN102266359A 一种从卷柏中连续提取降血糖活性成分和雌激素活性成分的方法 A continuous extraction method from Selaginella in hypoglycemic active ingredients and estrogen active ingredients |
| 12/07/2011 | CN102266349A 含有矿物质的活化碱性浓缩液 Activated alkaline concentrated liquid containing minerals |
| 12/07/2011 | CN102266329A 一种含长春西汀化合物的药物组合物及其制备方法 A pharmaceutical composition and preparation of compounds containing vinpocetine |
| 12/07/2011 | CN102266325A 一种二甲双胍晶体及其与沙格列汀的药用组合物与制备方法 One kind of metformin and saxagliptin crystals and pharmaceutical compositions and methods for preparing |
| 12/07/2011 | CN102266324A 一种κ-阿片受体激动剂的新用途 The new use of a κ- opioid receptor agonist |
| 12/07/2011 | CN102266323A 依折麦布和辛伐他汀组合物及其制备方法 Ezetimibe and simvastatin composition and its preparation method |
| 12/07/2011 | CN102266308A 掩味缓释大蒜素复合微囊的制备方法 Sustained-release preparation of taste-masked microcapsules allicin compound |
| 12/07/2011 | CN102266299A 葡萄糖酸锌化合物的组合物咀嚼片剂及其制备方法 The composition of zinc gluconate compound chewable tablet and its preparation method |
| 12/07/2011 | CN102266296A 一种瑞格列奈壳聚糖缓控释微球及其制备方法 Chitosan and its controlled release microsphere preparation repaglinide |
| 12/07/2011 | CN102028660B 一种格列齐特口服缓释干混悬剂及其制备方法 One kind of oral sustained-release gliclazide dry suspension and its preparation method |
| 12/07/2011 | CN101991622B Preparation process of Nitraria schoberi L seed oil liposome |
| 12/07/2011 | CN101966299B 治疗风疾性眩晕的药物 Vertigo wind disease treatment drug |
| 12/07/2011 | CN101966205B 一种无辅料超细粉片剂及其制备方法 A non-tablet accessories ultrafine powder and its preparation method |
| 12/07/2011 | CN101961342B 一种注射用水溶性维生素组合物及其制备方法 An injection with a water-soluble vitamin composition and its preparation method |
| 12/07/2011 | CN101940557B 一种脂溶性维生素冻干粉针的制备方法 Preparation method of freeze-dried powder of fat-soluble vitamins |
| 12/07/2011 | CN101851265B 一种从干罗汉果中提取多种活性成分的方法 A method of extracting stem from a variety of active ingredients Mangosteen |
| 12/07/2011 | CN101773517B H<sub>2</sub>S或H<sub>2</sub>S供体温度敏感性注射用即型凝胶制剂 H <sub> 2 </ sub> S or H <sub> 2 </ sub> S donor temperature-sensitive injectable gel formulations that |
| 12/07/2011 | CN101647785B 格列齐特缓释片及其制备方法 Gliclazide MR and its preparation method |
| 12/07/2011 | CN101642179B 一种具有降压、降糖、降脂的茶饮料 A kind of blood pressure, blood glucose, lipid-lowering tea |
| 12/07/2011 | CN101632655B 延缓衰老的白藜芦醇和生物类黄酮营养组合物 Anti-aging resveratrol and bioflavonoids nutritional composition |
| 12/07/2011 | CN101627993B 15种复合氨基酸液体制剂及其制备方法 15 kinds of amino acid liquid compound and its preparation method |
| 12/07/2011 | CN101606928B 化合物穗花衫双黄酮在制备降血脂药物方面的应用 Huashan biflavone compound spike in the preparation of lipid-lowering drugs |
| 12/07/2011 | CN101538568B 抑制人膜铁转运蛋白的rna、重组体及其应用 Rna inhibit human ferroportin, the recombinant and its applications |
| 12/07/2011 | CN101472600B 一种调节血糖、血脂的药物组合物及其制备方法和用途 For regulating blood sugar, blood lipids pharmaceutical composition and preparation method and use |
| 12/07/2011 | CN101434573B 低吸湿性阿立哌唑药物及其制备方法 Low hygroscopic aripiprazole drug and its preparation method |
| 12/07/2011 | CN101352253B 羽衣甘蓝红枣山楂菊花复合饮料 Kale dates Hawthorn chrysanthemum compound beverage |
| 12/07/2011 | CN101279011B 可快速恢复体力的营养剂 Quickly recuperate nutrients |
| 12/07/2011 | CN101278970B 东紫苏类黄酮的制备方法 Preparation East basil flavonoids |
| 12/07/2011 | CN101269102B 用于优生优育预防出生缺陷和改善记忆的药物组合物 Prenatal and postnatal care for the prevention of birth defects and improve memory pharmaceutical compositions |
| 12/07/2011 | CN101084193B (r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓盐酸盐的晶型 (R) -8- chloro-l-methyl-2,3,4,5-tetrahydro -1h-3- benzazepine hydrochloride crystalline form of |
| 12/07/2011 | CN101054344B 脂氧素A<sub>4</sub>类似物 Lipoxin A <sub> 4 </ sub> analogue |
| 12/07/2011 | CN101035522B Dpp-ⅳ抑制剂、ppar抗糖尿病剂和二甲双胍的组合 Dpp-ⅳ inhibitors, antidiabetic agents and metformin combination ppar |
| 12/06/2011 | US8071780 2-Hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide |
| 12/06/2011 | US8071650 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 12/06/2011 | US8071572 Hydroxypropylated starch; hyperlipidemia; visceral fat accumulation inhibitor, blood triglyceride level rise inhibitor |
| 12/06/2011 | US8071571 Orlistat compositions |
| 12/06/2011 | US8071558 Application of D-psicose to suppression of abnormal circadian increase in blood glucose level |
| 12/06/2011 | US8071549 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival cells |
| 12/06/2011 | US8071539 Albumin fusion proteins |
| 12/06/2011 | US8071141 Compositions for preventing or ameliorating multiple risk factor syndromes |
| 12/06/2011 | US8071096 Anti-C5aR antibodies and uses thereof |
| 12/06/2011 | CA2651573C Pyridopyrimidinone derivatives |
| 12/06/2011 | CA2619576C Crystalline rosuvastatin intermediate |
| 12/06/2011 | CA2584666C Pyrimidine derivative condensed with a non-aromatic ring |
| 12/06/2011 | CA2570807C Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 12/06/2011 | CA2517573C Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| 12/06/2011 | CA2504160C Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 12/06/2011 | CA2470837C Matrix-forming composition containing pectin |
| 12/06/2011 | CA2470791C Soft drink replacer |
| 12/06/2011 | CA2455620C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 12/06/2011 | CA2383522C Neurotherapeutic composition and method |
| 12/06/2011 | CA2328783C Human procalcitonin and the preparation and use thereof |
| 12/06/2011 | CA2305665C A method for treating diabetes, hyperglycemia and hypoglycemia |
| 12/01/2011 | WO2011150347A2 Non-peptide bdnf neurotrophin mimetics |
| 12/01/2011 | WO2011150286A2 Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
| 12/01/2011 | WO2011150279A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases |
| 12/01/2011 | WO2011150030A2 Method to alleviate diabetic end stage renal disease |
| 12/01/2011 | WO2011150008A1 Antibodies to human gdf8 |
| 12/01/2011 | WO2011149950A2 Bicyclic heteroaryl kinase inhibitors and methods of use |
| 12/01/2011 | WO2011149766A2 Lipid-tailored pharmaceutical agents |
| 12/01/2011 | WO2011149713A2 Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore |
| 12/01/2011 | WO2011149601A1 Treatment of vagally- mediated spectrum disorders with 5ht3 antagonists |
| 12/01/2011 | WO2011149356A1 Collagen powder |
| 12/01/2011 | WO2011149301A2 A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases |
| 12/01/2011 | WO2011149213A2 Novel derivative having inhibitory activity against 11β-hsd1, preparation method thereof, and pharmaceutical composition containing same as active ingredient |
| 12/01/2011 | WO2011149096A1 Insulin-resistance-improving drug |
| 12/01/2011 | WO2011149025A1 Body temperature rising agent for oral administration |
| 12/01/2011 | WO2011149011A1 Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 12/01/2011 | WO2011148922A1 Novel quinazoline compound |
| 12/01/2011 | WO2011148829A1 Pet food |
| 12/01/2011 | WO2011148657A1 Composition for prevention, amelioration or treatment of metabolic syndrome |
| 12/01/2011 | WO2011147980A1 Pharmaceutical composition comprising ave0010 and insulin glargine |
| 12/01/2011 | WO2011147951A1 Cycloamino derivatives as gpr119 antagonists |
| 12/01/2011 | WO2011147585A1 Compositions for use in the treatment of immune diseases, comprising 4 - phenyl -butyric acid and its salts |
| 12/01/2011 | WO2011147528A1 Biguanide compounds and its use for treating cancer |
| 12/01/2011 | WO2011147281A1 Aqueous formulation of vitamins and preparation method thereof |
| 12/01/2011 | WO2011147253A1 Polypeptides used for preventing and treating diabetes and lipid metabolic disorder |
| 12/01/2011 | WO2011147207A1 HEXAHYDROPYRROLO[3,4-b]PYRROLE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF |
| 12/01/2011 | WO2011147086A1 Microvesicles carrying small interfering rnas, preparation methods and uses thereof |
| 12/01/2011 | WO2011147038A1 Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof |
| 12/01/2011 | WO2011146981A1 Anti-diabetic compositions and methods |